Hyphens Pharma: General Announcement-Minutes of Annual General Meeting of the Company held on 25 April 2024
Hyphens Pharma: General Announcement-BUSINESS UPDATE FOR THE FIRST QUARTER ENDED 31 MARCH 2024
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Cash Dividend/ Distribution-Mandatory
Hyphens Pharma: Annual General Meeting-Voluntary
Hyphens Pharma: Annual Reports and Related Documents
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING
Hyphens Pharma: General Announcement-HYPHENS PHARMA LICENSES WYNZORA CREAM FOR ASEAN COUNTRIES FROM MC2 THERAPEUTICS
Hyphens Pharma: General Announcement-RESULTS BRIEFING FY2023
Hyphens Pharma: General Announcement-HYPHENS PHARMA'S CERADAN RANGE OF PRODUCTS TO ENTER MAJOR MIDDLE EAST MARKETS
Hyphens Pharma: Financial Statements and Related Announcement-Full Yearly Results
Hyphens Pharma: General Announcement-HYPHENS PHARMA PARTNERS 7-ELEVEN TO OFFER OCEAN HEALTH SUPPLEMENTS IN SINGAPORE
Hyphens Pharma: Employee Stock Option/ Share Scheme-GRANT OF SHARE AWARDS PURSUANT TO THE HYPHENS SHARE PLAN
Hyphens Pharma: General Announcement-QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2023
No Data